J&J unit Acclarent to pay $18 mln to settle false claims case
July 22, 2016 at 11:05 AM EDT
WASHINGTON, July 22 (Reuters) - Johnson & Johnson Inc subsidiary Acclarent Inc., a California-based medical device manufacturer, has agreed to pay $18 million to resolve allegations that it caused healthcare providers to submit false claims to Medicare and other federal healthcare programs, the Justice Department said on Friday.